These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 17968829)

  • 1. Lack of association between group B meningococcal disease and autoimmune disease.
    Howitz M; Krause TG; Simonsen JB; Hoffmann S; Frisch M; Nielsen NM; Robbins J; Schneerson R; Mølbak K; Miller MA
    Clin Infect Dis; 2007 Nov; 45(10):1327-34. PubMed ID: 17968829
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Risk of adverse birth outcome after group B meningococcal disease: results from a Danish national cohort.
    Howitz MF; Simonsen J; Krause TG; Robbins JB; Schneerson R; Mølbak K; Miller MA
    Pediatr Infect Dis J; 2009 Mar; 28(3):199-203. PubMed ID: 19165135
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Use of an observational cohort study to estimate the effectiveness of the New Zealand group B meningococcal vaccine in children aged under 5 years.
    Galloway Y; Stehr-Green P; McNicholas A; O'Hallahan J
    Int J Epidemiol; 2009 Apr; 38(2):413-8. PubMed ID: 18988650
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Meningococcal B vaccine: new drug. The only vaccine against some serogroup B meningococci.
    Prescrire Int; 2008 Jun; 17(95):95-7. PubMed ID: 18623907
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Meningococcal disease in catalonia 1 year after mass vaccination campaign with meningococcal group C polysaccharide vaccine.
    Cardeñosa N; Domínguez A; Martínez A; Alvarez J; Pañella H; Godoy P; Minguell S; Camps N; Vázquez JA;
    Infection; 2003 Dec; 31(6):392-7. PubMed ID: 14735381
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Emergence of endemic serogroup W135 meningococcal disease associated with a high mortality rate in South Africa.
    von Gottberg A; du Plessis M; Cohen C; Prentice E; Schrag S; de Gouveia L; Coulson G; de Jong G; Klugman K;
    Clin Infect Dis; 2008 Feb; 46(3):377-86. PubMed ID: 18181736
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Evolution of meningococcal infection among infant population in the autonomous community of Valencia (1996-2000). Effectiveness of A+C meningococcal vaccination].
    Goicoechea Sáez M; Fullana Montoro AM; Momparler Carrasco P; Redondo Gallego MJ; Brines Solanes J; Bueno Cañigral FJ
    Rev Esp Salud Publica; 2003; 77(1):125-42. PubMed ID: 12696392
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased case-fatality rate associated with outbreaks of Neisseria meningitidis infection, compared with sporadic meningococcal disease, in the United States, 1994-2002.
    Brooks R; Woods CW; Benjamin DK; Rosenstein NE
    Clin Infect Dis; 2006 Jul; 43(1):49-54. PubMed ID: 16758417
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epidemiologic investigation and targeted vaccination initiative in response to an outbreak of meningococcal disease among illicit drug users in Brooklyn, New York.
    Weiss D; Stern EJ; Zimmerman C; Bregman B; Yeung A; Das D; Dentinger CM; Marx MA; Kornblum J; Lee L; Halse TA; Mayer LW; Hatcher CP; Theodore MJ; Schmink S; Harcourt BH; Zucker JR; Layton M; Clark TA;
    Clin Infect Dis; 2009 Apr; 48(7):894-901. PubMed ID: 19231975
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Are antibodies to the capsular polysaccharide of Neisseria meningitidis group B and Escherichia coli K1 associated with immunopathology?
    Stein DM; Robbins J; Miller MA; Lin FY; Schneerson R
    Vaccine; 2006 Jan; 24(3):221-8. PubMed ID: 16125824
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Morbidity, mortality and spatial distribution of meningococcal disease, 1974-2007.
    Howitz M; Lambertsen L; Simonsen JB; Christensen JJ; Mølbak K
    Epidemiol Infect; 2009 Nov; 137(11):1631-40. PubMed ID: 19327198
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Characteristics of meningococcal meningitis in children in France].
    Levy C; Taha MK; Weill Olivier C; Quinet B; Lécuyer A; Alonso JM; Cohen R; Bingen E;
    Arch Pediatr; 2008 Dec; 15 Suppl 3():S105-10. PubMed ID: 19268239
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recent epidemiological changes in meningococcal disease may be due to the displacement of serogroup A by serogroup C in Hefei City, China.
    Ni JD; Jin YH; Dai B; Wang XP; Liu DQ; Chen X; Zheng Y; Ye DQ
    Postgrad Med J; 2008 Feb; 84(988):87-92. PubMed ID: 18322129
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Outcomes of meningococcal disease in adolescence: prospective, matched-cohort study.
    Borg J; Christie D; Coen PG; Booy R; Viner RM
    Pediatrics; 2009 Mar; 123(3):e502-9. PubMed ID: 19254985
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Meningococcal disease. The situation in Spain in the 1998-1999 period].
    Cano Portero R; García Delgado C; de Mateo Ontañón S
    Rev Esp Salud Publica; 2000; 74(4):369-75. PubMed ID: 11031845
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Effectiveness of an immunization campaign with group A and C meningococcal polysaccharide vaccine in controlling an outbreak of group C meningococcal disease].
    Gong J; Li CY; Dong BQ; Huang JZ; Quan Y; Lu WZ; Luo CH; Mao WC; Liao HZ; Fang JS; Cui XL; Xie GL; Wu XH; Lan RW
    Zhonghua Liu Xing Bing Xue Za Zhi; 2008 Jun; 29(6):552-5. PubMed ID: 19040035
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A prospective study of the effectiveness of the New Zealand meningococcal B vaccine.
    Kelly C; Arnold R; Galloway Y; O'Hallahan J
    Am J Epidemiol; 2007 Oct; 166(7):817-23. PubMed ID: 17615088
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The impact of childhood meningococcal serogroup C conjugate vaccine programs in Canada.
    Bettinger JA; Scheifele DW; Le Saux N; Halperin SA; Vaudry W; Tsang R;
    Pediatr Infect Dis J; 2009 Mar; 28(3):220-4. PubMed ID: 19209096
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The risk of simple febrile seizures after immunisation with a new group B meningococcal vaccine, New Zealand.
    Stehr-Green P; Radke S; Kieft C; Galloway Y; McNicholas A; Reid S
    Vaccine; 2008 Feb; 26(6):739-42. PubMed ID: 18187240
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Public health management in invasive meningococcal diseases].
    Ehrhard I; Arndt U
    Gesundheitswesen; 2004 Dec; 66(12):790-5. PubMed ID: 15609213
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.